Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 5, 2008, Pages 240-248

  Charoenphandhu, Narattaphol ^a   Teerapornpuntakit, Jarinthorn ^a   Methawasin, Methajit ^a   Wongdee, Kannikar ^a   Thongchote, Kanogwun ^a   Krishnamra, Nateetip ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Hyperprolactinemia; Mineralization; Osteocalcin; Osteopontin; Real time PCR

Indexed keywords

MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROLACTIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GENE REPRESSION; HYPERPROLACTINEMIA; MINERALIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TIBIA;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; OSTEOPROTEGERIN; POLYMERASE CHAIN REACTION; PROLACTIN; RANK LIGAND; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIBIA; TRANSCRIPTION, GENETIC;

EID: 43949092075     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-037     Document Type: Article

References (37)

1. Abdallah, B.M., Stilgren, L.S., Nissen, N., Kassem, M., Jorgensen, H.R., and Abrahamsen, B. 2005. Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures. Calcif. Tissue Int. 76: 90-97. doi:10.1007/s00223-004-0074-4. PMID:15570403.
2. Addison, W.N., Azari, F., Sørensen, E.S., Kaartinen, M.T., and McKee, M.D. 2007. Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J. Biol. Chem. 282: 15872-15883. doi:10.1074/jbc.M701116200. PMID: 17383965.
3. Aronow, M.A., Gerstenfeld, L.C., Owen, T.A., Tassinari, M.S., Stein, G.S., and Lian, J.B. 1990. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J. Cell. Physiol. 143: 213-221. doi:10.1002/jcp.1041430203. PMID:2332447.
4. Bakker, A., and Klein-Nulend, J. 2003. Osteoblast isolation from murine calvariae and long bones. In Methods in Molecular Medicine: Bone Research Protocols. Edited by M.H. Helfrich and S.H. Ralston. Humana Press, New Jersey. pp. 19-28.
5. Bataille-Simoneau, N., Gerland, K., Chappard, D., Basle, M.F., and Mercier, L. 1996. Expression of prolactin receptors in human osteosarcoma cells. Biochem. Biophys. Res. Commun. 229: 323-328. doi:10.1006/bbrc.1996.1800. PMID:8954126.
6. Bertaux, K., Broux, O., Chauveau, C., Jeanfils, J., and Devedjian, J.C. 2005. Identification of CBFA1-regulated genes on SaOs-2 cells. J. Bone Miner. Metab. 23: 114-122. doi:10.1007/s00774-004-0549-4. PMID:15750689.
7. Bezerra, F.F., Mendonca, L.M., Lobato, E.C., O'Brien, K.O., and Donangelo, C.M. 2004. Bone mass is recovered from lactation to postweaning in adolescent mothers with low calcium intakes. Am. J. Clin. Nutr. 80: 1322-1326. PMID:15531682.
8. Biller, B.M., Baum, H.B., Rosenthal, D.I., Saxe, V.C., Charpie, P.M., and Klibanski, A. 1992. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J. Clin. Endocrinol. Metab. 75: 692-697. doi:10.1210/jc.75.3.692. PMID: 1517356.
9. Bole-Feysot, C., Goffin, V., Edery, M., Binart, N., and Kelly, P.A. 1998. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr. Rev. 19: 225-268. doi:10.1210/er.19.3.225. PMID:9626554.
10. Charoenphandhu, N., and Krishnamra, N. 2007. Prolactin is an important regulator of intestinal calcium transport. Can. J. Physiol. Pharmacol. 85: 569-581. doi:10.1139/Y07-041. PMID: 17823618.
11. Clement-Lacroix, P., Ormandy, C., Lepescheux, L., Ammann, P., Damotte, D., Goffin, V., et al. 1999. Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology, 140: 96-105. doi:10.1210/en.140.1.96. PMID:9886812.
12. Coss, D., Yang, L., Kuo, C.B., Xu, X., Luben, R.A., and Walker, A.M. 2000. Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat. Am. J. Physiol. Endocrinol. Metab. 279: E1216-E1225. PMID:11093907.
13. Fazzalari, N.L., Kuliwaba, J.S., Atkins, G.J., Forwood, M.R., and Findlay, D.M. 2001. The ratio of messenger RNA levels of receptor activator of nuclear factor κB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. J. Bone Miner. Res. 16: 1015-1027. doi:10.1359/jbmr.2001.16.6.1015. PMID:11393778.
14. Grimaud, E., Soubigou, L., Couillaud, S., Coipeau, P., Moreau, A., Passuti, N., et al. 2003. Receptor activator of nuclear factor κB ligand (RANKL)/ osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am. J. Pathol. 163: 2021-2031. PMID: 14578201.
15. Haddad, P.M., and Wieck, A. 2004. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs, 64: 2291-2314. doi:10.2165/00003495-200464200-00003. PMID:15456328.
16. Haylock, D.N., and Nilsson, S.K. 2006. Osteopontin: a bridge between bone and blood. Br. J. Haematol. 134: 467-474. doi:10.1111/j.1365-2141.2006. 06218.x. PMID:16848793.
17. Hoang, Q.Q., Sicheri, F., Howard, A.J., and Yang, D.S. 2003. Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature, 425: 977-980. doi:10.1038/nature02079. PMID:14586470.
18. Honjo, S., and Mizunuma, H. 2001. Changes in biochemical parameters of bone turnover and bone mineral density in post-pregnancy osteoporosis. Am. J. Obstet. Gynecol. 185: 246-247. doi:10.1067/mob.2001.113910. PMID:11483939.
19. Jung, D.U., Conley, R.R., Kelly, D.L., Kim, D.W., Yoon, S.H., Jang, J.H., et al. 2006. Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional study. J. Clin. Psychiatry, 67: 1391-1396. PMID:17017825.
20. Koga, T., Matsui, Y., Asagiri, M., Kodama, T., de Crombrugghe, B., Nakashima, K., and Takayanagi, H. 2005. NFAT and osterix cooperatively regulate bone formation. Nat. Med. 11: 880-885. doi:10.1038/nm1270. PMID:16041384.
21. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89: 755-764. doi:10.1016/S0092-8674(00)80258-5. PMID:9182763.
22. Kostenuik, P.J. 2005. Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr. Opin. Pharmacol. 5: 618-625. doi:10.1016/j.coph.2005.06.005. PMID: 16188502.
23. 45Ca uptake, calcium deposit, and calcium resorption in weaned, young, and mature rats. Can. J. Physiol. Pharmacol. 74: 1157-1165. doi:10.1139/cjpp-74-10-1157. PMID:9022836.
24. 45Ca accumulation in rats. Endocr. J. 44: 257-264. doi:10.1507/endocrj.44.257. PMID:9228461.
25. Lambertini, E., Penolazzi, L., Tavanti, E., Schincaglia, G.P., Zennaro, M., Gambari, R., and Piva, R. 2007. Human estrogen receptor α gene is a target of Runx2 transcription factor in osteoblasts. Exp. Cell Res. 313: 1548-1560. doi:10.1016/j.yexcr.2007.02.002. PMID:17350616.
26. Liu-Seifert, H., Kinon, B.J., Ahl, J., and Lamberson, S. 2004. Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics. Ann. N. Y. Acad. Sci. 1032: 297-298. doi:10.1196/annals.1314.044. PMID:15677434.
27. Lotinun, S., Limlomwongse, L., Sirikulchayanonta, V., and Krishnamra, N. 2003. Bone calcium turnover, formation, and resorption in bromocriptine- and prolactin-treated lactating rats. Endocrine, 20: 163-170. doi:10.1385/ENDO:20:1-2:163. PMID: 12668882.
28. Puntheeranurak, S., Charoenphandhu, N., and Krishnamra, N. 2006. Enhanced trabecular-bone calcium deposition in female rats with a high physiological dose of prolactin diminishes after ovariectomy. Can. J. Physiol. Pharmacol. 84: 993-1002. doi:10.1139/Y06-047. PMID:17218965.
29. Ritchie, L.D., Fung, E.B., Halloran, B.P., Turnlund, J.R., Van Loan, M.D., Cann, C.E., and King, J.C. 1998. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am. J. Clin. Nutr. 67: 693-701. PMID:9537616.
30. Sengupta, S., Arshad, M., Sharma, S., Dubey, M., and Singh, M.M. 2005. Attainment of peak bone mass and bone turnover rate in relation to estrous cycle, pregnancy and lactation in colony-bred Sprague-Dawley rats: suitability for studies on pathophysiology of bone and therapeutic measures for its management. J. Steroid Biochem. Mol. Biol. 94: 421-429. doi:10.1016/j.jsbmb.2004.12.039. PMID:15876407.
31. Takagi, M., Kamiya, N., Takahashi, T., Ito, S., Hasegawa, M., Suzuki, N., and Nakanishi, K. 2004. Effects of bone morphogenetic protein-2 and transforming growth factor β1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells. J. Mol. Histol. 35: 81-90. doi:10.1023/B:HIJO.0000021151.31118.e3. PMID:15323353.
32. Takayama, T., Suzuki, N., Ikeda, K., Shimada, T., Suzuki, A., Maeno, M., et al. 2007. Low-intensity pulsed ultrasound stimulates osteogenic differentiation in ROS 17/2.8 cells. Life Sci. 80: 965-971. doi:10.1016/j.lfs.2006.11.037. PMID:17174343.
33. Ulrich, U., Miller, P.B., Eyre, D.R., Chesnut, C.H., 3rd, Schlebusch, H., and Soules, M.R. 2003. Bone remodeling and bone mineral density during pregnancy. Arch. Gynecol. Obstet. 268: 309-316. doi:10.1007/s00404-002- 0410-8. PMID: 14504876.
34. Wang, C., and Chan, V. 1982. Divergent effects of prolactin on estrogen and progesterone production by granulosa cells of rat Graafian follicles. Endocrinology, 110: 1085-1093. PMID: 6800769.
35. Wang, C., Hsueh, A.J., and Erickson, G.F. 1980. Prolactin inhibition of estrogen production by cultured rat granulosa cells. Mol. Cell. Endocrinol. 20: 135-144. doi:10.1016/0303-7207(80)90077-5. PMID:6777214.
36. Xiao, G., Jiang, D., Ge, C., Zhao, Z., Lai, Y., Boules, H., et al. 2005. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J. Biol. Chem. 280: 30689-30696. doi:10.1074/jbc.M500750200. PMID:16000305.
37. Young, D.W., Pratap, J., Javed, A., Weiner, B., Ohkawa, Y., van Wijnen, A., et al. 2005. SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation. J. Cell. Biochem. 94: 720-730. doi:10.1002/jcb.20332. PMID:15565649.